Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

Murphy, Tracy ; Mason, Jacqueline M ; Leber, Brian ; Bray, Mark R ; Chan, Steven M ; Gupta, Vikas ; Khalaf, Dina ; Maze, Dawn ; McNamara, Caroline J ; Schimmer, Aaron D ; Schuh, Andre C ; Sibai, Hassan ; Trus, Michael ; Valiquette, Debbie ; Martin, Kylie ; Nguyen, Linh ; Li, Xuan ; Mak, Tak W ; Minden, Mark D ; Yee, Karen W L

Leukemia, 2024-03, Vol.38 (3), p.502-512 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível